BIO-TECHNE Corp Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (13 lists). Names and jurisdictions are as filed.
- 2019-08-28: Subsidiary Research and Diagnostic Systems Inc. (R&D Systems); Jurisdiction Minnesota.
- 2019-08-28: Subsidiary Bionostics, Inc; Jurisdiction Massachusetts.
- 2019-08-28: Subsidiary Bio-Techne China Co. Ltd; Jurisdiction China.
- 2019-08-28: Subsidiary Shanghai PrimeGene Bio-Tech Co., Ltd.; Jurisdiction China.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2019-08-28 | Research and Diagnostic Systems Inc. (R&D Systems) | Minnesota |
| 2019-08-28 | Bionostics, Inc | Massachusetts |
| 2019-08-28 | Bio-Techne China Co. Ltd | China |
| 2019-08-28 | Shanghai PrimeGene Bio-Tech Co., Ltd. | China |
| 2019-08-28 | ProteinSimple | Delaware |
| 2019-08-28 | ProteinSimple Ltd. | Canada |
| 2019-08-28 | Novus Biologicals, LLC | Delaware |
| 2019-08-28 | Bio-Techne Ltd. | United Kingdom |
| 2019-08-28 | Tocris Cookson Limited | United Kingdom |
| 2019-08-28 | Cliniqa Corporation | California |
| 2019-08-28 | Advanced Cell Diagnostics, Inc. | California |
| 2019-08-28 | QT Holdings Corporation | Delaware |
| 2019-08-28 | Exosome Diagnostics, Inc. | Delaware |
| 2019-08-28 | B-MoGen Biotechnologies Inc. | Minnesota |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |